NCT02039011
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Asthma and Allergy Research Group, University of Dundee Dundee, United Kingdom
Clinical trial condition
Respiratory Hypersensitivity
Explore clinical trials studying Respiratory Hypersensitivity. Study availability and eligibility vary by location and protocol.
4,459 public trials
325 recruiting studies
Respiratory Hypersensitivity trial results
NCT01074853
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Asthma and Allergy Research Group, Unviersity of Dundee Dundee, United Kingdom
NCT00995657
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Asthma and Allergy Research Group, University of Dundee Dundee, Tayside, United Kingdom
NCT00679250
- Conditions
- Allergic Rhinitis, Hypersensitivity, Hypersensitivity, Immediate, +7 more
- Locations
-
- Ninewells Hospital and Medical School (Tayside NHS Trust, University of Dundee) Dundee, Angus, United Kingdom
- Perth Royal Infirmary Perth, Perthshire, United Kingdom
NCT00829257
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Asthma and Allergy Research Group, Ninewells Hospital and Medical School Dundee, Scotland, United Kingdom
NCT01946035
- Conditions
- Allergic Rhinitis, Hypersensitivity, Hypersensitivity, Immediate, +7 more
- Locations
-
- Brian Lipworth Dundee, United Kingdom
NCT01194700
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Asthma & Allergy Research Group, Department of cardiovascular & lung biology, Division of medicine, Ninewells Hospital & Medical School Dundee, Tayside, United Kingdom
NCT01070225
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Asthma and Allergy Research Group, Unviersity of Dundee Dundee, United Kingdom
NCT00831376
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Asthma and Allergy Research Group Dundee, Angus, United Kingdom
Completed
Efficacy and Safety of BI 655066/ABBV-066 (Risankizumab) in Patients With Severe Persistent Asthma
NCT02443298
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- WCCT Global, LLC Costa Mesa, California, United States
- El Camino Hospital Mountain View, California, United States
- IMMUNOe Research Centers Centennial, Colorado, United States
- Yale New Haven Hospital New Haven, Connecticut, United States